# Sickle Cell Treatment Demonstration Program (93.365)

Source: https://welltoldgrants.com/programs/93-365-sickle-cell-treatment-demonstration-program/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Sickle Cell Treatment Demonstration Program is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $27.0 million in 5 grants, about $5.4 million per award.

## Objectives

The objectives of this project is to support the development and establishment of systemic mechanisms to improve the prevention and treatment of sickle cell disease complications, including the coordination of service delivery for individuals with sickle cell disease; genetic counseling and testing; bundling of technical services related to the prevention and treatment of sickle cell disease; training of health professionals; and identifying and establishing efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with Sickle Cell Disease as authorized in 42 USC Section 300b-5(b) (Section 1106(b) of the Public Health Service Act).

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $5.0 million | 5 |
| 2022 | $5.0 million | 5 |
| 2023 | $6.0 million | 5 |
| 2024 | $5.3 million | 5 |
| 2025 | $5.8 million | 5 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| University of Alabama at Birmingham | Alabama | $6.2 million |
| The Johns Hopkins University | Maryland | $6.2 million |
| The Washington University | Missouri | $5.0 million |
| Childrens Hospital Medical Center | Ohio | $5.0 million |
| The Center for Comprehensive Care & Diagnosis of Inherited Blood Disorders | California | $5.0 million |